343 related articles for article (PubMed ID: 17459043)
1. Use of oral glycopyrronium bromide in hyperhidrosis.
Bajaj V; Langtry JA
Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
[TBL] [Abstract][Full Text] [Related]
2. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
Paller AS; Shah PR; Silverio AM; Wagner A; Chamlin SL; Mancini AJ
J Am Acad Dermatol; 2012 Nov; 67(5):918-23. PubMed ID: 22405644
[TBL] [Abstract][Full Text] [Related]
3. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis.
Kumar MG; Foreman RS; Berk DR; Bayliss SJ
Pediatr Dermatol; 2014; 31(1):e28-30. PubMed ID: 24266878
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
Walling HW
J Am Acad Dermatol; 2012 Mar; 66(3):387-92. PubMed ID: 21820204
[TBL] [Abstract][Full Text] [Related]
5. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate.
Luh JY; Blackwell TA
South Med J; 2002 Jul; 95(7):756-8. PubMed ID: 12144084
[TBL] [Abstract][Full Text] [Related]
6. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
Baumgartner FJ; Bertin S; Konecny J
Ann Vasc Surg; 2009; 23(1):1-7. PubMed ID: 18619780
[TBL] [Abstract][Full Text] [Related]
7. A medical alternative to the treatment of compensatory sweating.
Cladellas E; Callejas MA; Grimalt R
Dermatol Ther; 2008; 21(5):406-8. PubMed ID: 18844718
[TBL] [Abstract][Full Text] [Related]
8. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M
Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700
[No Abstract] [Full Text] [Related]
9. The efficacy of oral anticholinergics for sympathetic overactivity in a thoracic surgery clinic.
Hynes CF; Seevaratnam S; Gesuwan K; Margolis M; Marshall MB
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):565-8. PubMed ID: 27160942
[TBL] [Abstract][Full Text] [Related]
10. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
[TBL] [Abstract][Full Text] [Related]
11. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis.
Arnold MJ; O'Connor C
Am Fam Physician; 2019 Sep; 100(6):372-373. PubMed ID: 31524358
[No Abstract] [Full Text] [Related]
12. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
[TBL] [Abstract][Full Text] [Related]
13. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
Siscos SM; Figenshau K; Rajpara A
J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717
[No Abstract] [Full Text] [Related]
14. Topical glycopyrrolate for patients with facial hyperhidrosis.
Kim WO; Kil HK; Yoon KB; Yoon DM
Br J Dermatol; 2008 May; 158(5):1094-7. PubMed ID: 18294315
[TBL] [Abstract][Full Text] [Related]
15. A unique pattern of hyperhidrosis.
Lewis VJ; Holt PJ
Arch Dermatol; 2006 Feb; 142(2):264. PubMed ID: 16490867
[No Abstract] [Full Text] [Related]
16. [Successful treatment of diabetic gustatory hyperhidrosis with topical glycopyrrolate].
Lund NS; Maxel T; Rungby J
Ugeskr Laeger; 2011 Sep; 173(36):2200-1. PubMed ID: 21893005
[TBL] [Abstract][Full Text] [Related]
17. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
[TBL] [Abstract][Full Text] [Related]
18. Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
Madan V; Beck MH
Br J Dermatol; 2006 Sep; 155(3):634-5. PubMed ID: 16911300
[No Abstract] [Full Text] [Related]
19. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Hotline: Topical glycopyrrolate: a successful treatment for craniofacial hyperhidrosis and eccrine hidrocystomas.
Garnacho Saucedo GM; Moreno Jiménez JC; Jiménez Puya R; Rodríguez Bujaldon A
Dermatol Ther; 2010; 23(1):94-7. PubMed ID: 20136914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
